Check out our projects and collaborations

Cherry Biotech is rooted in academics labs. Our first CherryTemp technology has been originally developped at the Institut Curie and the ENS Paris during CEO Jeremy Cramer’s PhD work.

We naturally follow on building tight relationships with academic labs as we know that basic science is the breeding ground of innovation. Our challenge is to transfer ideas into technologies and make them available for the scientific community. Our partners are precious advisors for our developments.


DeLIVER is a European consortium where PhD students will be trained to super-resolution (nanoscopy) with a unique goal of live imaging nanopores of a Liver-on-a-chip. Indeed, going through the optical diffraction limit set by the Abbe law is key to observe nanoscaled structures like the nanopores of endothelial barriers. To achieve this goal, cutting-edge techniques combining SR-SIM, high speed and high resolution nanoscopy and microfluidic devices will allow live cell imaging of 3D cell culture.

EUROSTARS | i-Bracelet

Pre-eclampsia is a pathology affecting 10% of pregnant women. The main symptom is high blood pressure. The i-bracelet project aims at developing a connected wristband for the detection of pre-eclampsia, by continuously measuring the blood pressure, thanks to a microfluidic based sensor. The i-bracelet project addresses two challenges : to build a highly sensitive sensor and to develop a reliable algorithm for the symptom detection. Cherry Biotech is the project coordinator and collaborates with 4 partners in France and Romania.


DivIDE is a European consortium where PhD students are trained to cell cycle, cell division and cutting-edge techniques ranging from cell biology to biochemistry. Students are hosted in top-level groups and institutes (London CRIK, Institut Curie Paris, CRG Barcelona, MPI Dortmund, Dresden, Heidelberg). The project aims to investigate the mechanisms and principles of cell division and to reproduce them in vitro with synthetic approaches. LEARN MORE.


Cherry360 comes from CEO Jeremy Cramer and CNRS Research Director Damien Coudreuse meeting in 2013. Both convinced that the technology developed by Jeremy was valuable for biological labs, they wrote a co-development project which had been supported by local actors until 2016 (Région Bretagne, ID2Santé). The project aimed at developing a microfluidic platform for the environmental control and high resolution imaging of yeast cells. LEARN MORE.


SpOC project comes from a close collaboration between Cherry Biotech and the Institut de Génétique De Rennes (IGDR). Since both partners are convinced that 3D cell culture is the future of cell culture they naturally decided to merge their expertise within a common project. The project aimed at developing a microfluidic device allowing the long-term culture and live imaging of spheroids. It opens the perspectives of personalized medicine and more efficient drug development.

This is a unique website which will require a more modern browser to work! Please upgrade today!